BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16363628)

  • 1. 111In-pentetreotide and 123I-MIBG for detection and resection of lymph node metastases of a carcinoid not visualized by CT, MRI or FDG-PET.
    Yüksel M; Eziddin S; Ladwein E; Haas S; Biersack HJ
    Ann Nucl Med; 2005 Oct; 19(7):611-5. PubMed ID: 16363628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-111 DTPA octreotide scintigraphy and intraoperative gamma probe detection in the diagnosis and treatment of residual lymph node metastases of a rectal carcinoid tumor.
    Banzo J; Vidal-Sicat S; Prats E; Galofré G; Razola P; Mañé S; Ubieto MA; Abós MD
    Clin Nucl Med; 2005 May; 30(5):308-11. PubMed ID: 15827397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of radioguided surgery with [111In]-pentetreotide in the management of an ACTH-secreting bronchial carcinoid causing ectopic Cushing's syndrome.
    Grossrubatscher E; Vignati F; Dalino P; Possa M; Belloni PA; Vanzulli A; Bramerio M; Marocchi A; Rossetti O; Zurleni F; Loli P
    J Endocrinol Invest; 2005 Jan; 28(1):72-8. PubMed ID: 15816375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
    Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
    Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
    Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease.
    Zuetenhorst JM; Hoefnageli CA; Boot H; Valdés Olmos RA; Taal BG
    Nucl Med Commun; 2002 Aug; 23(8):735-41. PubMed ID: 12124478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma.
    Muros MA; Llamas-Elvira JM; Rodríguez A; Ramírez A; Gómez M; Arráez MA; Valéncia E; Vílchez R
    Nucl Med Commun; 1998 Aug; 19(8):735-42. PubMed ID: 9751927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
    Bomanji J; Mather S; Moyes J; Ellison D; Grossman A; Britton KE; Besser GM
    J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.
    Taal BG; Hoefnagel CA; Valdés Olmos RA; Boot H
    Eur J Cancer; 1996 Oct; 32A(11):1924-32. PubMed ID: 8943676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.
    Dörr U; Räth U; Sautter-Bihl ML; Guzman G; Bach D; Adrian HJ; Bihl H
    Eur J Nucl Med; 1993 May; 20(5):431-3. PubMed ID: 8100192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
    Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
    Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
    Oberg K; Eriksson B
    Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):265-76. PubMed ID: 15763700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreoscan in patients with bronchial carcinoid tumours.
    Granberg D; Sundin A; Janson ET; Oberg K; Skogseid B; Westlin JE
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):793-9. PubMed ID: 14974924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [111IN-octreotide and 123I-MIBG scintigraphy in the diagnosis of small intestinal carcinoid tumors--results of a comparative investigation].
    Dresel S; Tatsch K; Zachoval R; Hahn K
    Nuklearmedizin; 1996 Apr; 35(2):53-8. PubMed ID: 8721576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
    Kaltsas GA; Putignano P; Mukherjee JJ; Satta MA; Lowe DG; Britton KE; Monson JP; Grossman AB; Besser GM
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):685-9. PubMed ID: 10197087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The radioguided 111In-pentetreotide surgery in the management of ACTH-secreting bronchial carcinoid.
    Porziella V; Cesario A; Lococo F; Cafarotti S; Margaritora S; D'Errico G; Granone P
    Eur Rev Med Pharmacol Sci; 2011 Jun; 15(6):587-91. PubMed ID: 21796863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I-123 MIBG imaging of metastatic carcinoid tumor from the rectum.
    Watanabe N; Seto H; Ishiki M; Shimizu M; Kageyama M; Wu YW; Nagayoshi T; Kamisaki Y; Kakishita M
    Clin Nucl Med; 1995 Apr; 20(4):357-60. PubMed ID: 7788995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine tumors and somatostatin: imaging techniques.
    de Herder WW; Kwekkeboom DJ; Valkema R; Feelders RA; van Aken MO; Lamberts SW; van der Lely AJ; Krenning EP
    J Endocrinol Invest; 2005; 28(11 Suppl International):132-6. PubMed ID: 16625862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.
    Ezziddin S; Logvinski T; Yong-Hing C; Ahmadzadehfar H; Fischer HP; Palmedo H; Bucerius J; Reinhardt MJ; Biersack HJ
    J Nucl Med; 2006 Feb; 47(2):223-33. PubMed ID: 16455627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.